Phase II study of Paclitaxel and Nedaplatin for previously untreated patients with advanced squamous cell lung cancer.
Not Applicable
- Conditions
- Squamous cell lung cancer
- Registration Number
- JPRN-UMIN000008872
- Lead Sponsor
- Tochigi Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 17
Inclusion Criteria
Not provided
Exclusion Criteria
1.Symptomatic Brain metastasis. 2.History of active double cancer. 3.Severe infection. 4.Severe comorbidity (heart failure Tendency to hemorrhages uncontrollable hypertension, uncontrollable diabetes, etc) 5.Interstitial pneumonia or pulmonary fibrosis detectable on X ray. 6.With a history of drug sensitivity. 7.Pregnant or lactating women or those who declined contraception. 8.Any other medical condition that makes the patient unsuitable for inclusion in the study according to the opinion of the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method